The European Commission non-food Scientific Committees Scientific Committee on consumer safety - SCCS

Similar documents
TTC NON-CANCER ORAL DATABASES

Cancer thresholds, Cohort of Concern and other excluded substance groups

1st SETAC Europe Special Science Symposium

Thresholds of Toxicological Concern

Use of TTC and Human Relevance George E. N. Kass, PhD

Using the TTC for evaluation of substances ingested at low levels through food: Challenges and perspectives

Threshold of Toxicological Concern Overview of Ongoing Scientific Developments

SAFETY ASSESSMENT OF FOOD CONTACT MATERIALS. Threshold of Toxicological Concern Lisette Krul

Recent Progress in the Risk Assessment of FCMs. Laurence Castle

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Joint meetrag of the Earopean Commission Scieatäfíc Committees and the Еигореав

Threshold of Toxicological Concern (TTC):

SCIENTIFIC / TECHNICAL REPORT submitted to EFSA

Computational Modelling for TTC Assessment

Impact of genotoxicity in risk assessment of pesticides, their metabolites and degradates

Threshold of Toxicological Concern Approach in Regulatory Decision- Making: The Past, Present, and Future

Threshold of Toxicological Concern an approach for safety assessment and its applicability to cosmetics-related chemicals. July 24, 2014 Chihae Yang

CHEMICAL IDENTITY. INCI NAME: propylene glycol IUPAC: propane-1,2-diol CAS: EC NUMBER: EMPIRICAL FORMULA: C3H8O2 STRUCTURAL FORMULA:

FORUM The Threshold of Toxicological Concern Concept in Risk Assessment

Thought Starter Combined Exposures to Multiple Chemicals Second International Conference on Risk Assessment

The CEFIC LRI. of the CPDB. of Departure Analysis. Project B18: Update. Database and Point. Sylvia Escher Fraunhofer ITEM

Genotoxicity Testing Strategies: application of the EFSA SC opinion to different legal frameworks in the food and feed area

Draft OPINION ON. Use of the Threshold of Toxicological Concern (TTC) Approach for the Safety Assessment of Chemical Substances

Trigger values for active substances, relevant and non-relevant metabolites in Ground Water/ Drinking water

TTC and science. Hans Muilerman, PAN Europe

Dose response relationships: biological and modeling aspects

STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH AN ACUTE REFERENCE DOSE

Risk Assessment Report on Tris (nonylphenyl)phosphite (TNPP)

Introduction. Dietary Exposure Assessment Tools for Prioritizing Food Safety Concerns. Workshop on. Stephen S. Olin

Part 2. Chemical and physical aspects

PQRI PODP Extractables & Leachables Workshop Derivation of the Parenteral Safety Concern Threshold (SCT)

PQRI PODP Extractables & Leachables Workshop Leachable Evaluation of a Container Closure System - What to do When Above the Threshold

Low dose effect Alan R Boobis Imperial College London ILSI Europe March 2014 Annual Symposium Brussels, Belgium

FAQs on bisphenol A in consumer products

The Italian approach to the safety assessment of coatings intended for food contact application

cccta 17ème Journées Scientifiques, Les Diablerets VD

Risk Assessment Report on. Bis(hydroxylammonium)sulfate. CAS No.: EINECS no.:

Basic Principles of API Risk Assessment

Regulation of Genotoxic and Carcinogenic Impurities in

Absorption, Distribution, Metabolism, Excretion and Toxicology

Incorporating Computational Approaches into Safety Assessment

Toxicological tool. Sarah O Meara, PhD, MSc PharmMed Non-clinical Assessor. GMP Conference 12 th November 2014

Threshold Establishment and Rationale. Douglas J Ball, MS, DABT Research Fellow Pfizer Worldwide R&D

GSC CODEX MESSAGE CCFA48/2016/25

Risk Assessment of Chemicals in Foods- WHO Principles and Methods

Development of a Novel Method for Deriving Thresholds of Toxicological Concern (TTCs) for Vaccine Constituents

BENZETHONIUM CHLORIDE

Dermal Occupational Exposure Limits. Their use in risk assessment

Risk assessment of mycotoxins: the EFSA approach. Katleen Baert Scientific officer, EFSA

Opinion on Voluntary Risk Assessment Report on lead and lead compounds. Human Health Part

Regarding Establishment of a Uniform Limit in a Positive List System concerning Agricultural Chemicals Residues in Food etc.

Current state of play on FCMs, including the risk assessment Eric Barthélémy, EFSA FCM team

Risk Assessment Report on Hexachlorocyclopentadiene (HCCP) Human Health Part. CAS No.: EINECS No.:

OVERVIEW OF FOOD SAFETY ASSESSMENT NOVEL INGREDIENTS & ADDITIVES

Case Study Application of the WHO Framework for Combined Exposures. Presented by: M.E. (Bette) Meek University of Ottawa

Action Levels and Allergen Thresholds What they will mean for the Food Industry Dr. Rachel WARD r.ward consultancy limited

Dr. Joerg Feesche November 2016 How to Determine Safety of a Food Contact Adhesive

Scientific Committee on Consumer Safety (SCCS) 8 th PLENARY Venue: Luxembourg. Meeting date: 16 December Minutes

EFSA Info Session on Applications. Technical meeting on food flavourings applications. Parma, 20 th January 2015

The Universe of Expanded (EDT) Decision Trees and Threshold of Toxicological Concern (TTC)

European public MRL assessment report (EPMAR)

Scientific Committee on Consumer Products SCCP OPINION ON. Toluene. (its use as a solvent in nail cosmetics)

Step by Step Approach for GPS Risk Assessment

Opinion on. Risk Assessment Report on NITROBENZENE. Human Health Part. CAS No: EINECS No:

SCIENTIFIC OPINION. EFSA Panel on food contact materials, enzymes, flavourings and processing aids (CEF) 2, 3

Provisional Translation Original: Japanese

Methodologies for development of human health criteria and values for the lake Erie drainage basin.

APPLICATION FOR AUTHORISATION: ESTABLISHING A REFERENCE DOSE RESPONSE RELATIONSHIP FOR CARCINOGENICITY OF INORGANIC ARSENIC COMPOUNDS

The EFSA scientific opinion on lead in food

OpenFoodTox and Other Open Source In silico EFSA. Jean Lou Dorne Senior Scientific Officer Scientific Committee and Emerging Risks Unit EFSA

The use of dose response data for risk assessment

Tocopherols (E ) used in foods for infants below 16 weeks of age

TNsG on Annex I Inclusion Revision of Chapter 4.1: Quantitative Human Health Risk Characterisation

- draft scientific opinion -

Minutes of EFSA-ANSES Expert Meeting on Bisphenol A (BPA) Art. 30 Regulation (EC) No 178/2002 Held on 3 December 2014, Paris (France)

CHAPTER 9: SPECIAL CONSIDERATIONS

The Director General Maisons-Alfort, 30 July 2018 OPINION. of the French Agency for Food, Environmental and Occupational Health & Safety

Cosmetic Product Safety Report

CONCEPTUAL FRAMEWORK FOR A TIERED APPROACH TO RISK RANKING AND PRIORITIZATION

3-MCPD and glycidol and their esters

Risk Assessment Report on styrene. Human Health Part

Risk Assessment Report on Diphenylamine. Human Health Part. CAS No.: EINECS No.:

EU policy on acrylamide in food reducing human exposure to ensure a high level of human health protection

COMMISSION REGULATION (EU)

BfR Proposal for a Harmonised Procedure for Estimating the Dermal Absorption

Databases, Tools and TTC Approach Applied To Chemicals In Cosmetics Products. March 2014 Chihae Yang

Reporting and interpretation of uncertainties for risk management

Emanuela Turla Scientific Officer Nutrition Unit - EFSA

DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *)

EFSA working group on BPA assessment protocol. Ursula Gundert-Remy Chair of the EFSA Working Group BPA assessment Protocol

Risk Assessment Report on Alkanes, C 14-17, chloro MCCP. Human Health Part. CAS No.: EINECS no.:

MINERAL HYDROCARBONS IN COSMETIC LIP CARE PRODUCTS. ***** Recommendation *****

Comments from PlasticsEurope

Development of NJ Human Health-based Criteria and Standards

EFSA Guidance on residue definition for dietary risk assessment

Status of Activities on BPA

EFSA Info Session Pesticides 26/27 September Anja Friel EFSA Pesticides Unit (Residues team)

COSMETIC PRODUCT SAFETY REPORT

APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELs FOR 1-BROMOPROPANE (1-BP)

Practical guidance for applicants on the submission of applications on food additives, food enzymes and food flavourings

Use of Bridging Justifications to Support the Safety of Excipients in Generic Drug Products

Transcription:

The European Commission non-food Scientific Committees Scientific Committee on consumer safety - SCCS Health and Consumers

Threshold of toxicological concern (TTC) Cosmetics a special case? Thomas Platzek, Berlin Health and Consumers

TTC Threshold of Toxicological Concern Thesis Dependent on the structure, an exposure dose with low concern of systemic toxicity can be set for any substance even in the absence of substance specific toxicity data Precondition Procedure Knowledge of structure and exposure Classification into a toxicity class (Cramer) following a decision tree and definition of a TTC value Class TTC µg/person/day TTC µg/kg bw/d Genotoxicity alert 0.15 0.0025 Organophosphate, Carbamate 18 0.3 Cramer Class III 90 1.5 Cramer Class II 540 9 Cramer Class I 1800 30 Kroes et al. 2004 T. Platzek, TTC Brussels 2014 Page 3

EFSA flow chart Is the substance a member of an exclusion category? * Yes Substance not expected to be of safety concern ** No No No Is there a structural alert for genotoxicity (including metabolites)? No Exposure > 0.3 µg/kg bw/day? *** Is substance an OP/Carbamate? No Yes Yes Exposure > 1.5 µg/kg bw/day? *** Exposure > 0.0025 µg/kg bw/day? No Low probability of safety concern ** Yes Yes Substance requires non-ttc approach (toxicity data, read-across etc.) No Yes Is substance in Cramer Class II or III? No Exposure > 30 µg/kg bw/day? *** Yes Yes * Exclusion categories high potency carcinogens; inorganic substances; metals; proteins; steroids; substances known/predicted to bioaccumulate; insoluble nanomaterials; radioactive substances. ** If exposure of infants < 6 months is in range of TTC consider if TTC is applicable *** If exposure only short duration consider margin between human exposure & TTC value T. Platzek, TTC Brussels 2014 Page 4

TTC database (Munro et al. 1990 ff) 613 substances, oral toxicity data chronic, subchronic, reproductive and developmental toxicity sources: NTP, JECFA, IRIS (integrated risk information system) EPA, DART (developmental and reproductive toxicology) RepDose (Escher, Mangelsdorf 2009) ITEM Fraunhofer Institute ca. 600 industrial chemicals, subchronic and chronic toxicity TTC RepDose (Tluczkiewicz et al. 2011) Combined database Databases ELINCS (Kalkhoff et al. 2011) 861 new industrial notified chemicals, subacute and subchronic toxicity FCM (Pinalli et al. 2011) Comparison of TDI/NOAEL of 845 FCM substances (232 in addition to Munro) with TTC: 96% of the TTCs was lower Cosmetics COSMOS project COLIPA + EU Commission + ILSI

Database of carcinogenic substances CPDB carcinogenic potency database (Gold et al. 1984 ff) Contains now 730 carcinogenic substances Linear extrapolation from TD 50 value to a virtual safe dose (VSD) (dose exhibiting 1 x 10-6 risk) Kroes et al. 2004 0.5 ppb in diet = 1.5 µg / person = 25 ng/kg bw Exclusion of high potency classes (aflatoxin, N-nitroso, azoxy) Substances with structural alert for genotoxicity TTC 0.15 µg / person = 2.5 ng/kg bw Comment of the EU SCs 1. The CPDB contains a number substances for which the VSD is below 0.15 µg/person per day, and which do not fall within the three groups of high potency carcinogens recommended for exclusion by Kroes et al. (2004). 2. Further work is necessary to strengthen the scientific basis for the TTC value of 0.15 µg/person per day for genotoxic carcinogens. 3. It was proposed to derive VSD only from recognized human carcinogens (e.g. IARC classified 166 substances)

Some crucial points Cramer classes Cramer et al. (1978) based their decision tree on a series of 33 questions relating mostly to chemical structure, and natural occurrence in food and in the body were also taken into consideration. The logic of the sequential questions was based on the then available knowledge on toxicity and on how chemical structures are metabolised in mammalian metabolic pathways. Toxtree software Use of the Kroes et al. (2004) TTC decision tree results in three possible outcomes: (a) not be expected to be a safety concern, (b) negligible risk (low probability of a life-time cancer risk 1 in 10 6 ), and (c) risk assessment requires compound-specific data. Toxtree incorporates the Benigni/Bossa rules for the identification of some genotoxic carcinogens (Benigni et al. 2008), and requires the user to input the estimated daily intake (exposure). Chemoinformatic analysis Chemical space analysis (structure, size, shape, reactivity) was performed to analyse if Munro database is representative for world of chemicals.

Application of TTC in cosmetics Kroes et al. 2007 Consideration of: 1. Similarity between cosmetic ingredients and the Munro database 2. Route-dependent differences in first-pass metabolism dermal vs. oral 3. Default factors for percutaneous absorption 4. Estimation of aggregate internal exposure Conclusion of the authors For many of the cosmetic ingredients groups TTC may be applicable. More extensive first pass metabolism in the liver, compared with the skin Slower and incomplete transfer across the skin compared with the intestinal wall, due to different physiological properties Slower absorption after topical application may result in a different shape of the plasma concentration time curve, even if the area under the curve is identical.

Default adjustment factors for percutaneous absorption Prediction of percutaneous absorption Log K p = 2.7 + 0.71 x log P - 0.0061 x MW (correction for lipophilic compounds ) K P = permeability coefficient (cm/h) P = octanol water partition coefficient MW = molecular weight J max = K P (corrected) x C (saturation, in water) J max maximum flux Classification of chemicals (on the basis of their physicochemical properties) in terms of their potential to be absorbed across the skin Jmax (µg/cm 2 /h) MW (Da) logp Category Jmax = 0 > 1000 Da Any Negligible Jmax < 0.1 > 300 < 1 or > 5 Low 0.1 < Jmax < 1.0 200 300 > 2.0, 2.5 Medium low 1.0 < Jmax < 10 150 250 1.0 2.0 Medium high 10 < Jmax < 100 60 200 0.5 3.5 High Jmax > 100 <150 0.5 2.0 High

Default adjustment factors for percutaneous absorption Proposed default adjustment factors for the % dose absorbed of cosmetic ingredients across the skin Jmax (µg/cm 2 /h) MW > 1000 Default % dose absorbed per 24 h Negligible Jmax < 0.1 10 0.1 < Jmax < 10 40 Jmax > 10 80 Default adjustment factors for rinse-off products Skin contact < 1 h, default retention factors 1% (e.g. shower gel or 10% (e.g. hair dyes) Default adjustment factors for intermittent use Time interval > 7 days once per week factor 3 Less than once per week factor 10

Assessment by SCCS/SCHER/SCENIHR 1. TTC database and cosmetic ingredients a) Munro database 613 substances vs COSING database 9 286 CAS RNs and 19 390 INCI names b) Certain structural classes are missing (e.g. organometallics, silicones, non-ionic and cationic surfactants). c) Chemicals with complex structures are not adequately covered in the Munro database. It is necessary to include toxicity data on these compounds and other complex structures (e.g. UV-filters) into the database to be used for derivation of TTCs for cosmetics. d) Reality check: comparison of TTC-derived values with experimental TDIs of cosmetic ingredients to check for misclassification. e) Chemical space analysis is being performed, i.e. comparison of intrinsic properties (size, shape) and derived properties (chemical reactivity).

Assessment by SCCS/SCHER/SCENIHR 2. Exposure assessment a) Dermal absorption SCCS Notes of Guidance: In case the results are derived from an inadequate in vitro study, 100% dermal absorption is used. In case MW > 500 Da and log Pow is smaller than -1 or higher than 4, the value of 10% dermal absorption is considered. b) Comment of the SCs: The use of an adjustment factor for percutaneous absorption needs further elaboration based on a broad systematic comparison of predicted and experimentally obtained percutaneous absorption values c) Comment of the SCCS to adjustment for intermittent exposure If exposure is only for a number of days per year, the exposure value is the actual dose on the exposure days, and not the daily dose averaged out (and thus divided!) over the whole year [EChA 2008b, exception genotoxic carcinogens!]. d) Default adjustment factors for rinse-off products The SCCS adjustment factors are used since 2003 and are generally accepted.

Assessment by SCCS/SCHER/SCENIHR 3. Route-to route extrapolation MOS calculation according to Notes of Guidance SCCS: MOS = NOAEL / SED NOAEL oral subchronic toxicity study CAVE: oral absorption is rarely known, default 50% SED dermal absorption in vitro determination of the amount systemically available In the case of orally poorly absorbed substances the MOS is not conservative For cosmetic ingredients any risk assessment as well as the TTC approach should be based on internal doses (internal TTC).

Assessment by SCCS/SCHER/SCENIHR 4. TTC for chemicals with genotoxicity alert TTC approach: - reference point TD 50 of the Gold database - linear extrapolation - exclusion of high potency classes Criticism SCs: 4.1% of the substances in the Gold database have a cancer risk > 10-6 at the TTC 2.5 ng/kg bw/d For 1/3 of human carcinogens the TTC is not protective TD 50 is not the adequate reference point for extrapolation No allometric scaling Proposal SCs: Acceptance of the TTC value only preliminarily Reconsider the TTC value: The probability that exposure to an untested genotoxic carcinogen results in a cancer risk higher than 1 x 10-6 should be minimized. - extending the database to cover all available studies - using allometric adjustment factors and/or using the T25 or 1, 5 or 10% benchmark dose as point of departure for linear extrapolation.

Assessment by SCCS/SCHER/SCENIHR 5. Further critical points a) Dose descriptor Comparison of toxicity of chemicals might be better addressed by expressing doses (potencies) on a molar basis (mmol/kg bw/day). Usually, TTC is expressed in dose per person per day. The SCs advise to express TTC in dose per body weight per day b) Infants Give special consideration to infants under the age of 6 months because of the the potentially immature metabolism for some chemicals structures, in particular when the estimated exposure is in the range of the TTC value. c) Classification Several recent analyses have revealed regular misclassification of compounds when using the Cramer decision tree in its present form. The SCs accept in principle the division into Class I and Class III. For Class I, classification should be carefully considered and justified. If classification in Class I cannot be justified the SCs recommend using Cramer Class III. All scientific information available today should be used to define the various toxicity classes before expanding the number of classes, i.e. the classification scheme should be modified based on up-to-date toxicological knowledge and recent developments e.g. QSAR.

Conclusion Regulatory toxicologists in Europe have been discussing the TTC approach since more than a decade, e.g. the previous SCF 1996. Two European committees have discussed possible applications. The EFSA Scientific Committee issued an opinion exploring options for the application in food and feed, e.g. for impurities of food additives, thermal reaction products, food contact materials, contaminants etc. An EU non-food expert Committee consisting of members of SCCS, SCHER and SCHENIR discussed the TTC concept in general as well as additional possible fields of application with the focus on cosmetics. Major aspects to be considered are applicability domain, route to route extrapolation and exposure assessment. COSMOS project: comparison of TTC and experimentally derived TDIs, chemical space analysis, prediction of human repeated dose toxicity For cosmetic ingredients the TTC approach should be based on internal doses. Prediction of exposure to cosmetic ingredients should use a probabilistic procedure whenever possible and remains a challenge.

Conclusion The TTC approach as presently proposed is in general acceptable. It needs, however, further research and refinement with regard to Cramer classification as well as for the TTC value for substances with genotoxicity alert. The refinement of the TTC approach should take into account the up-to-date toxicological knowledge including QSAR. There is no distinction between toxicity induced either by intentionally added ingredients or inadvertent contaminants. However, primary ingredients added to products are often regulated, also certain cosmetic ingredients (e.g. preservatives). A requirement for toxicity testing data is appropriate for such substances. With cosmetics specific problems may arise in praxi: According to the new EU cosmetic legislation the safety of cosmetic products available on the market has to be assessed by the manufacturer or importer. Assessors in small enterprises with limited toxicological experience may apply the TTC approach, e.g. by running the TOXTREE software. Therefore, a cosmetic-specific decision tree has to be built to minimize misuse of the approach.

THANK YOU Health and Consumers